Side-by-side comparison of AI visibility scores, market position, and capabilities
San Jose CA data observability platform; raised $55M+; monitors data pipeline health, quality, and compute cost across multi-cloud data environments.
Acceldata is a data observability and data pipeline monitoring company founded in 2018 and headquartered in San Jose, California, with engineering operations in Bengaluru, India. The company was founded by Rohit Choudhary and Achal Agarwal, data infrastructure veterans from Hortonworks and other enterprise data companies, to provide deep operational visibility into modern data environments. As data stacks became more complex with multiple data platforms, streaming pipelines, and warehouse compute, data engineering teams lacked a unified view of pipeline health, data quality, and infrastructure cost — problems Acceldata was built to solve.\n\nAcceldata raised $55 million across two funding rounds led by March Capital and Insight Partners. Its platform covers four pillars of data observability: data reliability monitoring for detecting anomalies in data freshness, completeness, and distribution; pipeline observability for tracking job health, latency, and failure rates across Spark, Airflow, dbt, and other orchestration tools; compute intelligence for analyzing and optimizing cloud warehouse and data platform costs; and data quality testing for defining and validating data quality rules. This breadth distinguishes Acceldata from narrower data observability tools that focus primarily on data quality checks.\n\nAcceldata supports complex enterprise data environments including multi-cluster Hadoop, Spark, Databricks, Snowflake, BigQuery, Redshift, and Kafka, reflecting its roots in large-scale enterprise data platforms. Its compute intelligence capability is a differentiator, providing cost attribution down to the team, job, and user level so data platform owners can identify waste and enforce cost governance in cloud warehouse environments where runaway compute costs are a common problem.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.